To issue task C19 entitled, "efficacy of amoxicillin and amoxicillin/clavulanate in NHP model of anthrax." period of performance: september 1, 2013 through december 31, 2014.

Ended Awarded Last action

Contract number
HHSN27200004
Awardee
Awarding agency
Obligated
$2,101,458

Award facts

Contract value 100% obligated
$2,101,458.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 4 offers Multiple Award, Fair Opportunity
Pricing
Cost Plus Fixed Fee
Place of performance
Great Britain, United Kingdom

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00008 · To exercise option 5. The period of performance is october 31, 2019 to october 30, 2020 $347
Exercise an Option P00007 · To exercise option 4. The period of performance is october 31, 2018 to october 30, 2019 $347
Funding Only Action 6 · To DE-obligate expiring FY13 funding -$56,319
Exercise an Option 5 · Exercise option 3 for storage- extend term to october 30, 2018 the period of performance of this contract has changed from october 30, 2017 to october 30, 2018 $347
Exercise an Option 4 · Exercise option 2 for storage- extend term to october 31, 2017 the period of performance of this contract has changed from september 1, 2013 to february 28,… $347
Exercise an Option 3 · Exercise option 1 for storage- extend term to october 31, 2016 the period of performance of this contract has changed from september 1, 2013 to february 28,… $347
Other Administrative Action 2 $0
Other Administrative Action 1 · The period of performance of this contract has changed from september 1, 2013 to december 31, 2014 to september 1, 2013 to february 28, 2015. $0
Original award $2,156,042

About this award

Written by GovTribe AI ·

The National Institute of Allergy and Infectious Diseases issued a delivery order to Public Health England on August 21, 2013, under the NIAID Animal Models of Infectious Diseases 2010-2017 IDIQ with a ceiling value of $2,101,458.

The initial task, Task C19, titled "Efficacy of Amoxicillin and Amoxicillin/Clavulanate in NHP Model of Anthrax," ran from September 1, 2013 through December 31, 2014. Option 5 was subsequently exercised, with a period of performance from October 31, 2019 to October 30, 2020. Work is performed in Great Britain, United Kingdom. The delivery order is priced on a cost-plus-fixed-fee basis with no set-aside applied.

Quick answers

Who was awarded contract HHSN27200004?

HHSN27200004 was awarded to Public Health England by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 21, 2013.

How much is contract HHSN27200004 worth?

The government has obligated $2,101,458 on HHSN27200004.

Is contract HHSN27200004 an order under another contract?

Yes. HHSN27200004 is a delivery order under HHSN272201000013I, an indefinite delivery contract, on NIAID Animal Models of Infectious Diseases 2010-2017.

Was contract HHSN27200004 competed?

The extent of competition for HHSN27200004 was full and open competition. The government received 4 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login